Can we use EBV-DNA monitoring to predict disease relapse in EBV-positive hodgkin lymphoma patients?
Spacek
Martin
M
Department of Clinical Hematology, University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic. m.spacek@fnkv.cz
Hubacek
P
P
Markova
J
J
Zajac
M
M
Vernerova
Z
Z
Kozak
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D004279:DNA, Viral / Q000097:blood*; D005260:Female; D004854:Herpesvirus 4, Human / Q000235:genetics*; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000473:pathology / Q000821:virology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D012008:Recurrence; D019562:Viral Load; D055815:Young Adult
D004279:DNA, Viral